The DOI matches its Crossref record.
Hypoglycemia in the Diabetes Control and Complications Trial
Abstract
A total of 1,441 patients with IDDM were randomly assigned to receive either intensive (n = 711) or conventional (n = 730) diabetes therapy in the Diabetes Control and Complications Trial (DCCT). The patients were followed for an average of 6.5 years. Subjects were instructed to report all episodes of suspected severe hypoglycemia to their health care team. In addition, at quarterly follow-up visits, each subject was asked about the occurrence of severe hypoglycemia. There were 3,788 episodes of severe hypoglycemia (requiring assistance); 1,027 of these episodes were associated with coma and/or seizure. A total of 65% percent of patients in the intensive group vs. 35% of patients in the conventional group had at least one episode of severe hypoglycemia by the study end; the overall rates of severe hypoglycemia were 61.2 per 100 patient-years vs. 18.7 per 100 patient-years in the intensive and conventional treatment groups, respectively, with a relative risk (RR) of 3.28. The relative risk for coma and/or seizure was 3.02 for intensive therapy. The increased risk with intensive treatment persisted over each of the 9 years of follow-up in the DCCT and over the calendar years 1984–1993 during which the study was conducted. When baseline patient characteristics were examined for effects on the risk of severe hypoglycemia, the relative risk of hypoglycemia for intensive versus conventional treatment was ≥2 for all subgroups. Several subgroups defined by baseline characteristics, including males, adolescents, and subjects with no residual C-peptide or with a prior history of hypoglycemia, had a particularly high risk of severe hypoglycemia in both treatment groups. Analyses of the cumulative incidence of successive episodes indicated that intensive treatment was also associated with an increased risk of multiple episodes within the same patient (e.g., 22% experienced five or more episodes of severe hypoglycemia within the first 5 years of follow-up vs. 4% in the conventional group). Within both treatment groups, patients who experienced severe hypoglycemia were at increased risk of subsequent episodes. Approximately 30% of patients in each group experienced a second episode within the 4 months following the first episode of severe hypoglycemia. Within each treatment group, the number of prior episodes of hypoglycemia was the strongest predictor of the risk of future episodes, followed closely by the current HbA1c value. After adjustment for the current quarterly HbA1c level, intensive treatment was still associated with a significantly increased risk of hypoglycemia, indicating that the increased risk with intensive treatment is not completely explained by differences in HbA1c values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized controlled trials have established that intensive glycemic therapy prevents or delays the microvascular complications-retinopathy, nephropathy, and neuropathy-of diabetes (122, 123, 131, 144, 145), albeit at the expense of an increased frequency of hypoglycemia (117, 118, 122, 123, 132, 133, 144, 145).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [133]
In the citing paper
“A glucose of <70 mg/dL (3.9 mmol/L) is the classic threshold for hypoglycemia based on physiologic glucose regulation and neuroendocrine response in persons without DM.1197”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1197]
Citations
Cites
Still being checked.
Cited by
Items 401–500 of 779
Conget, I., Ávila, D., Giménez, M., Quirós, C., Salaverría, V., & Dueñas, B. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.11.003 · Cited by 21
Rangasamy, V., Xu, X., Susheela, A., & Subramaniam, B. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.12.032 · Cited by 25
Suzuki, J., Urakami, T., Yoshida, K., Kuwabara, R., Mine, Y., Aoki, M., & Morioka, I. (2020) · Pediatrics International · doi:10.1111/ped.14412 · Cited by 26
The effect of intensive glycaemic control on cardiovascular outcomes
Hill, D., & Fisher, M. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01199.x · Cited by 24
Severe hypoglycaemia in drug-treated diabetic patients needs attention: A population-based study
Honkasalo, M., Elonheimo, O., & Sane, T. (2011) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2011.580090 · Cited by 22
Li, X., Gao, M., Zhang, S., Xu, H., Zhou, H., Wang, X.-H. F., Qu, Z., Guo, J., Zhang, W., & Tian, D. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7589184 · Cited by 24
Zhong, V. W., Juhaeri, J., Cole, S. R., Shay, C. M., Gordon‐Larsen, P., Kontopantelis, E., & Mayer‐Davis, E. J. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.10.008 · Cited by 22
Role of Glucagon in Automated Insulin Delivery
Wilson, L. M., Jacobs, P. G., & Castle, J. R. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.008 · Cited by 25
Hypoglycemia Reduction and Accuracy of Continuous Glucose Monitoring
Kovatchev, B. P. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0144 · Cited by 22
Long-Term Metabolic Effects of Continuous Subcutaneous Insulin Infusion Therapy in Type 1 Diabetes
Cohen, N. D., Hong, E. S., Drie, C. V., Balkau, B., & Shaw, J. E. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0331 · Cited by 21
Truman, L. A., Pękalski, M. Ł., Kareclas, P., Evangelou, M., Walker, N. M., Howlett, J., Mander, A., Kennet, J., Wicker, L. S., Bond, S. J., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009799 · Cited by 20
Beck, S. E., Kelly, C., Price, D. A., & for the COACH Study Group (2021) · Diabetic Medicine · doi:10.1111/dme.14739 · Cited by 27
Baidal, D. A., Ballou, C., Rickels, M. R., Berney, T., Pattou, F. N., Payne, E. H., Barton, F. B., Alejandro, R., & CITR Investigators (2023) · Diabetes Care · doi:10.2337/dc22-1155 · Cited by 29
Pant, T., Lin, C., Bedrat, A., Jia, S., Roethle, M. F., Truchan, N. A., Ciecko, A. E., Chen, Y., & Hessner, M. J. (2024) · Science Advances · doi:10.1126/sciadv.adn2136 · Cited by 23
Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes
Donner, T. W., & Joseph, J. J. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s50286 · Cited by 22
Chen, J. ‐., Lauritzen, T., Bojesen, A., & Christiansen, J. S. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00557.x · Cited by 22
George, P., Tavendale, R., Palmer, C. N. A., & McCrimmon, R. J. (2015) · Diabetes · doi:10.2337/db14-1539 · Cited by 22
Predicting and Reducing Driving Mishaps Among Drivers With Type 1 Diabetes
Cox, D. J., Gonder-Frederick, L. A., Singh, H., Ingersoll, K. S., Banton, T. A., Grabman, J. H., Schmidt, K., & Clarke, W. L. (2017) · Diabetes Care · doi:10.2337/dc16-0995 · Cited by 21
Structured education in type 1 diabetes
Heller, S. R. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409351646 · Cited by 21
Hypoglycaemia after pancreas transplantation: usefulness of a continuous glucose monitoring system
Esmatjes, E., Flores, L., Vidal, M., Rodríguez, L., Cortés, A., Almirall, L., Ricart, M. J., & Gomis, R. (2003) · Clinical Transplantation · doi:10.1046/j.1399-0012.2003.00101.x · Cited by 21
Inouye, K., Yue, J. T. Y., Chan, O. T. M., Kim, T., Akirav, E. M., Park, E., Riddell, M. C., Burdett, E., Matthews, S. G., & Vranić, M. (2006) · Endocrinology · doi:10.1210/en.2005-1040 · Cited by 26
Pacaud, D., Hermann, J., Karges, B., Rosenbauer, J., Danne, T., Dürr, R., Herbst, A., Lindauer, S. P., Müther, S., Pötzsch, S., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12610 · Cited by 20
Nielens, N., Pollé, O. G., Robert, A. R., & Lysy, P. A. (2018) · Journal of Diabetes Research · doi:10.1155/2018/5936360 · Cited by 22
Bao, S., Briscoe, V. J., Tate, D. B., & Davis, S. N. (2009) · Diabetes · doi:10.2337/db09-0382 · Cited by 19
Lower A1c among adolescents with lower perceived A1c goal: a cross-sectional survey
Clements, S. A., Anger, M. D., Bishop, F. K., McFann, K. K., Klingensmith, G. J., Maahs, D. M., & Wadwa, R. P. (2013) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2013-17 · Cited by 19
Klaprat, N. D., MacIntosh, A., & McGavock, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00042 · Cited by 22
Carlson, N. E., Horton, K. W., Hokanson, J. E., Cleary, P. A., Jacobs, D. R., Brunzell, J. D., & Purnell, J. Q. (2022) · Diabetic Medicine · doi:10.1111/dme.14794 · Cited by 22
Heinemann, L., Deiss, D., Hermanns, N., Graham, C., Kaltheuner, M., Liebl, A., & Price, D. A. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815575999 · Cited by 20
Feigerlová, E., Oussalah, A., Zuily, S., Sordet, S., Braun, M., Guéant, J., & Guerci, B. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3313 · Cited by 21
Zou, H., Liu, L., Guo, J., Wang, H., Liu, S., Xing, Y., Deng, C., Xiao, Y., & Zhou, Z. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13387 · Cited by 21
Insight into hypoglycemia in pediatric type 1 diabetes mellitus
Sawyer, K. E., Renukuntla, V. S., & Heptulla, R. A. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-19 · Cited by 23
Tierney, S., Webb, A. K., Jones, A. M., Dodd, M. E., McKenna, D., Rowe, R., Whitehouse, J. L., & Deaton, C. (2008) · Chronic Illness · doi:10.1177/1742395308094240 · Cited by 21
Zhu, L., Ang, L. C., Tan, W. B., Xin, X., Bee, Y. M., Goh, S., & Teh, M. M. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018817707422 · Cited by 19
Can Continuous Glucose Monitoring Provide Objective Documentation of Hypoglycemia Unawareness?
Streja, D. A. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.83 · Cited by 20
Sigurðardóttir, Á. K. (1999) · Journal of Clinical Nursing · doi:10.1046/j.1365-2702.1999.00279.x · Cited by 24
Cryer, P. E., & Arbeláez, A. M. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch35 · Cited by 26
Microencapsulation in Clinical Islet Xenotransplantation
Shimoda, M., & Matsumoto, S. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6364-5_25 · Cited by 18
Effect of Automated Bio-Behavioral Feedback on the Control of Type 1 Diabetes
Kovatchev, B. P., Mendosa, P., Anderson, S. M., Hawley, J. S., Ritterband, L. M., & Gonder-Frederick, L. A. (2011) · Diabetes Care · doi:10.2337/dc10-1366 · Cited by 19
Could Online Education Replace Face-to-Face Education in Diabetes? A Systematic Review
Alonso-Carril, N., Rodriguez-Rodríguez, S., Quirós, C., Berrocal, B., Amor, A. J., Barahona, M. J., Martínez, D., Ferré, C., & Perea, V. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01595-6 · Cited by 21
Can we reduce hypoglycaemia with insulin detemir?
Mathieu, C. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802748 · Cited by 19
Diabetes management: optimizing roles for nurses in insulin initiation
Levich, B. (2011) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s16451 · Cited by 24
Glycaemic control, glucose variability and the Triangle of Diabetes Care
Rayman, G. A. (2016) · British Journal of Diabetes · doi:10.15277/bjd.2016.070 · Cited by 18
Jeon, J. Y., Kim, S. R., Kim, H. J., Kim, D. J., Lee, K. W., Lee, J.-D., & Han, S. J. (2016) · Medicine · doi:10.1097/md.0000000000005365 · Cited by 22
Pilgaard, K. A., Breinegaard, N., Johannesen, J., Pörksen, S., Fredheim, S., Madsen, M., Kristensen, K., Svensson, J., & Birkebæk, N. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13020 · Cited by 19
Hermanns, N., Ehrmann, D., Heinemann, L., Freckmann, G., Waldenmaier, D., & Calhoun, P. M. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0130 · Cited by 18
Injectable nanosized formulation for glucose-responsive insulin delivery
Wang, Y., Chen, P., Liu, W., Wei, X., Zhang, J., Wei, X., Liu, Y., Rao, L., Zhang, S., Yu, J., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101937 · Cited by 19
Furusawa, S., Nomoto, H., Yokoyama, H., Suzuki, Y., Tsuzuki, A., Takahashi, K., Miya, A., Kameda, H., Cho, K. Y., Takeuchi, J., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15393 · Cited by 19
Treatment of Mild Hypoglycemia
Evert, A. B. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.1.58 · Cited by 17
Lessons learned from the International trial of the Edmonton protocol for islet transplantation
Hirshberg, B. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0048-9 · Cited by 17
Severe Hypoglycemia and the Role of the Significant Other: Expert, Sentry, and Protector
King, J., Overland, J., Fisher, M., & White, K. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715606223 · Cited by 18
Fritzen, K., Basinska, K., Rubio-Almanza, M., Nicolucci, A., Kennon, B., Vergès, B. L., Zakrzewska, K. E., & Schnell, O. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819835172 · Cited by 18
Florez, C. M., Lukankin, V., Sugumar, S., McGinn, R. J., Zhang, Z. J., Zhang, L., & Carlen, P. L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.005 · Cited by 18
Sämann, A., Lehmann, T., Kloos, C., Braun, A., Hunger-Dathe, W., Wolf, G., & Müller, U. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02406.x · Cited by 17
Effectiveness and Safety of Medication Adjustments by Nurse Case Managers to Control Hyperglycemia
Curtis, J., Lipke, S., Effland, S., Dickinson, B., McCabe, A., Russell, B., Russell, M., Bloomquist, P., & Wilson, C. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709343677 · Cited by 17
Access to emergency room for hypoglycaemia in people with diabetes
Salutini, E., Bianchi, C., Santini, M., Dardano, A., Daniele, G., Penno, G., Miccoli, R., & Prato, S. D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2667 · Cited by 18
Practical Management of Type 1 Diabetes Mellitus in Adolescent Patients: Challenges and Goals
Hoffman, R. P. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403010-00004 · Cited by 20
Intelligent alarms integrated in a multi-agent architecture for diabetes management
Hernando, M. E., García-Sáez, G., Aguilera, E. J. G., & del Pozo, F. (2004) · Transactions of the Institute of Measurement and Control · doi:10.1191/0142331204tm119oa · Cited by 16
Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans
Oltmanns, K. M., Deininger, E., Wellhoener, P., Schultes, B., Kern, W., Marx, E., Dominiak, P., Jan Born, A., Fehm, H. L., & Peters, A. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01771.x · Cited by 16
Kilpatrick, E. S., Rigby, A. S., Warren, R. E., & Atkin, S. L. (2012) · Diabetic Medicine · doi:10.1111/dme.12075 · Cited by 15
LaGamma, E. F., Kirtok, N., Chan, O. T. M., & Nankova, B. B. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2014 · Cited by 15
Schnell, O., Erbach, M., & Wintergerst, E. S. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700413 · Cited by 16
Exposure to insulin degludec during pregnancy: report of a small series and review of the literature
Bonora, B. M., Avogaro, A., & Fadini, G. P. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0926-9 · Cited by 16
Ndebele, N., Mack, J. P., & Nyokong, T. (2018) · Electroanalysis · doi:10.1002/elan.201800651 · Cited by 15
Management of Type 1 Diabetes in Children and Adolescents
Jain, V. (2013) · The Indian Journal of Pediatrics · doi:10.1007/s12098-013-1196-3 · Cited by 16
Characteristics of glycemic control in young children with type 1 diabetes
KAUFMAN, F. R., Austin, J., Lloyd, J., Halvorson, M., Carpenter, S., & Pitukcheewanont, P. (2002) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2002.30402.x · Cited by 15
Ristic, S., & BATES, P. C. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503763816472 · Cited by 16
Fetal Risk Assessment in Pregnancies Complicated by Diabetes Mellitus
Zisser, H., Biersmith, M. A., Jovanovič, L., Yogev, Y., Hod, M., & Kovatchev, B. P. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400610 · Cited by 17
Dyrl�v, K., Povlsen, L., S�lvk�r, L., Marinelli, K., Olsen, B. S., Hougaard, P., & Mortensen, H. B. (2000) · Practical Diabetes · doi:10.1002/1528-252x(200010)17:7<217::aid-pdi45>3.0.co;2-q · Cited by 15
Defining quality of care for children and adolescents with type 1 diabetes
Daneman, D., & Frank, M. (1998) · Acta Paediatrica · doi:10.1111/j.1651-2227.1998.tb01245.x · Cited by 15
Tasende, C., Rubio, J. A., & Álvarez, J. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.12.003 · Cited by 14
Hashim, R., Forde, R., Ausili, D., & Forbes, A. (2023) · Diabetic Medicine · doi:10.1111/dme.15173 · Cited by 17
Automated Insulin Delivery: The Artificial Pancreas Technical Challenges
Hernando, M. E., García-Sáez, G., Aguilera, E. J. G., Gandía, C. P., & Rodríguez-Herrero, A. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001086 · Cited by 17
El Páncreas Artificial: Control Automático de Infusión de Insulina en Diabetes Mellitus Tipo 1
Bondía, J., Vehí, J., Palerm, C. C., & Herrero, P. (2010) · Revista Iberoamericana de Automática e Informática Industrial RIAI · doi:10.1016/s1697-7912(10)70021-2 · Cited by 27
Which patients should be evaluated for blood glucose variability?
Candido, R. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12141 · Cited by 16
Uso de bomba de infusão subcutânea de insulina e suas indicações
Minicucci, W. J. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200022 · Cited by 14
Archibald, P., & Williams, D. J. (2015) · Regenerative medicine · doi:10.2217/rme.15.59 · Cited by 14
Nishimura, M., Iizuka, N., Fujita, Y., Sawamoto, O., & Matsumoto, S. (2017) · Xenotransplantation · doi:10.1111/xen.12313 · Cited by 14
Villani, M., Earnest, A., Smith, K. L., Giannopoulos, D., Soldatos, G., de Courten, B. V., & Zoungas, S. (2019) · Diabetologia · doi:10.1007/s00125-019-4933-y · Cited by 16
Impact of therapeutic advances on hypoglycaemia in type 2 diabetes
Boyle, P. J., & Zrebiec, J. F. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.795 · Cited by 14
Challenges and Strategies for Moving Patients to Injectable Medications
Siminerio, L. M. (2006) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721706287653 · Cited by 14
Pedersen‐Bjergaard, U., Thomsen, C. E., Høgenhaven, H., Smed, A., Kjær, T. W., Holst, J. J., Dela, F., Hilsted, L., Frandsen, E., Pramming, S., et al. (2008) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2008.001 · Cited by 14
Outcome Measures for Outpatient Hypoglycemia Prevention Studies
Beck, R. W., Kollman, C., Xing, D., Buckingham, B. A., & Chase, H. P. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500423 · Cited by 14
Sjöberg, S., Ahrén, B., & Bolinder, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01043.x · Cited by 13
Madar, H., Wu, Z., Bandini, A., Perkins, B. A., Messier, V., Pomey, M., Brazeau, A., & RABASA-LHORET, R. P. R. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01987-9 · Cited by 14
The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?
Naqvi, R. A., Naqvi, A. R., Singh, A. R., Priyadarshini, M., Balamurugan, A. N., & Layden, B. T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1001041 · Cited by 18
Review: The importance of residual endogenous beta-cell preservation in type 1 diabetes
Ali, M. A., & Dayan, C. M. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409351881 · Cited by 21
Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies
Pistrosch, F., & Hanefeld, M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0678-2 · Cited by 13
Takita, M., Matsumoto, S., Qin, H., Noguchi, H., Shimoda, M., Chujo, D., Itoh, T., Sugimoto, K., Onaca, N. N., Naziruddin, B., et al. (2011) · Cell Transplantation · doi:10.3727/096368911x580617 · Cited by 16
Miller, R. G., & Costacou, T. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1240-4 · Cited by 15
Weitgasser, R., & Lopes, S. H. K. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0626-1 · Cited by 17
Herbst, A., Roth, C. L., Dost, A., Fimmers, R., & Holl, R. W. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1723-y · Cited by 13
Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
Long-Term Prediction of Severe Hypoglycemia in Type 1 Diabetes: Is It Really Possible?
Henriksen, M. M., Færch, L., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816664745 · Cited by 12
Hypoglycemic episodes in cats with diabetes mellitus: 30 cases (2013–2015)
Viebrock, K. A., & Dennis, J. (2017) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x17722853 · Cited by 18
Knudsen, S. T., Lapolla, A., Schultes, B., Tentolouris, N., Catarig, A., Wolden, M. L., & Siegmund, T. (2019) · Diabetic Medicine · doi:10.1111/dme.13976 · Cited by 11
Impact of clinical pharmacy specialists on glycemic control in veterans with type 2 diabetes
Schmidt, K., Caudill, J., & Hamilton, T. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxy015 · Cited by 13
Bernasko, J. (2007) · Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050601144727 · Cited by 13
Strategies to prevent type 1 diabetes
Thrower, S., & Bingley, P. J. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01064.x · Cited by 13
Revisiting hypoglycemia in diabetes
Gehlaut, R. R., & Shubrook, J. H. (2013) · Osteopathic Family Physician · doi:10.1016/j.osfp.2013.08.002 · Cited by 11
Saboo, B., Garg, S. K., Bergenstal, R. M., Battelino, T., Ceriello, A., Choudhary, P., de Bock, M. I., Elbarbary, N. S., Forlenza, G. P., Gómez, A. M., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0028 · Cited by 12
Metadata
- Authors
- The Diabetes Control and Complications Trial Research Group
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- The Diabetes Control and Complications Trial Research Group
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-02-01
- Volume
- 46
- Issue
- 2
- Pages
- 271-286
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W4252271922
- Semantic Scholar
- 0b14f6e58470afda31b2a9daa1c3fb61be7dad5a
- Cited by
- 746
- References
- 0
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 30 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 36 · 2015: 47 · 2014: 45 · 2013: 36 · 2012: 33
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, type 1 diabetes, intensive insulin therapy, baseline characteristics, Diabetes Control and Complications Trial, hypoglycemia risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.